KERN Stock Jumps After Announcing Deal with PAX Labs

KERN stock

KERN stock is gaining momentum after Akerna Corp (NASDAQ:KERN) announced an agreement with PAX Labs.

Major Details

Akerna, which is involved in providing regulatory compliance solutions to the global cannabis industry, made a major announcement this morning. The company announced that it has signed an agreement with leading customer services company PAX Labs so that it can provide better service to its clients.

PAX Labs is going to provide Akerna with actionable insights about its business so that it can then implement these as and when required. It is a significant development for the company, and the market seemed to welcome the news of the deal as well.

>> Tilray Stock Gains on Receipt of EU GMP Certification

Akerna is one of the biggest companies in the cannabis compliance space, and the deal could also have a knock-on effect for the wider industry. After all, the company has overseen cannabis sales worth $10 billion since 2010.

KERN stock has gained as much as 3% so far this morning, and it goes without saying that it is likely that Akerna stock is going to be on the radars of many investors.

Separately, Akerna announced that it is going to release its financial results for the fiscal second quarter 2020 on February 12. The conference call will commence on the same day at 4:30 P.M. ET or at 2:30 P.M. MT. The quarterly earnings will reveal the company’s performance for the three month period that ended on December 31, 2019.

The Chief Executive Officer of the company, Jessica Billingsley, and John Fowle, the Chief Financial Officer, are going to feature in the aforementioned conference call. They will talk about the company’s performance and also provide information on some of the latest events with regards to Akerna’s operations. Those who call in will also be able to participate in a question and answer session afterward.

KERN stock has doubled over the past three months.

>> Read More Cannabis News

Featured image: DepositPhotos © minervastock